Skip to search.
 FTSE 100 Down 1.50%

Horizon Pharma plc (HZNP)

-NasdaqGS
29.61 Down 0.54(1.79%) 3 Sep 21:00
Add to Portfolio
Prev Close:30.15
Open:30.46
Bid:29.00 x 200
Ask:30.99 x 400
1y Target Est:42.43
Beta:1.93756
Next Earnings Date:N/A
Day's Range:29.48 - 30.54
52wk Range:9.46 - 39.49
Volume:2,462,841
Avg Vol (3m):3,123,080
Market Cap:4.71b
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for HZNP at this time.

Comparison

Symbol% ChgMkt Cap
HZNPDown 1.79%4.71b
ABTDown 0.23%65.79b
POZNDown 5.08%278.82m
PFEDown 0.25%196.68b

Key Statistics

Forward P/E (1 yr):15.18
P/S (ttm):10.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :1.42
Quarterly EPS Est (Sep-15) :0.40
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):1.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback